Agrigenomics Market (Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Tecan Genomics Inc., BGI, Illumina, Inc., Eurofins Scientific SE, LGC Limited, Arbor Biosciences, Biogenetic Services Inc., Galseq Srl Via Italia, and Others.) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global agrigenomics market size reached USD 4.02 billion in 2023 and is expected to hit around USD 9.98 billion by 2033, poised to grow at a CAGR of 9.52% from 2024 to 2033.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The U.S. agrigenomics market size was valued at USD 1.30 billion in 2023 and is anticipated to reach around USD 3.23 billion by 2033, poised to grow at a CAGR of 9.55% from 2024 to 2033.
North America led the market with the biggest market share of 43% in 2023 due to North America is often at the forefront of technological innovations, and this applies to the field of agrigenomics. Advances in DNA sequencing technologies, gene editing tools, and bioinformatics contribute to the growth of the agrigenomics market. North America has a robust and technologically advanced agricultural sector. The adoption of agrigenomic technologies is driven by the need to enhance crop yields, improve livestock productivity, and address challenges related to climate change and sustainability. Moreover, ongoing research and development activities in genomics and molecular biology, conducted by academic institutions, private companies, and government agencies, contribute to the expansion of agrigenomics applications in North America.
Additionally, Government support through funding, grants, and favorable regulatory frameworks can play a crucial role in promoting the adoption of agrigenomic technologies. Policies that encourage sustainable and innovative agricultural practices further drive market growth.
Asia-Pacific is poised for rapid growth in the agrigenomics market due to Asia-Pacific region is home to diverse climates and a wide range of crops and livestock. The agrigenomics market benefits from the need to optimize agricultural productivity, improve crop resilience, and ensure food security. With a rapidly growing population, there is an increasing demand for food. Agrigenomics technologies can contribute to developing high-yielding crops and improving livestock productivity to meet the rising food requirements in the region.
Meanwhile, Europe is growing at a notable rate in the agrigenomics market. Europe has a strong tradition of research and innovation in the fields of genomics, molecular biology, and agriculture. Ongoing research initiatives and collaborations between academic institutions, research organizations, and biotechnology companies contribute to the growth of the agrigenomics market. Europe has established regulatory frameworks that address biotechnological applications in agriculture, including genetically modified organisms (GMOs). The approval and regulation of genetically modified crops and gene-edited organisms can impact the adoption of agrigenomics technologies in the region.
Agrigenomics, also known as agricultural genomics, refers to the application of genomics and advanced molecular biology techniques in the study of crops, livestock, and other agricultural organisms. It involves the analysis of the genetic material (DNA, RNA, and proteins) of plants and animals to understand their genetic makeup, traits, and interactions.
The primary goal of agrigenomics is to enhance agricultural productivity, sustainability, and the overall efficiency of food production. The market encompasses a range of technologies and services, including DNA sequencing, genotyping, marker-assisted selection, gene editing, and bioinformatics. These tools allow researchers, breeders, and farmers to gain insights into the genetic variations that influence traits such as yield, disease resistance, and nutritional content.
The agrigenomics market has seen significant growth due to advancements in genomic technologies, increased demand for sustainable and high-yielding agricultural practices, and the need to address global food security challenges. Companies in the agrigenomics market may offer sequencing services, genetic testing kits, bioinformatics tools, and other solutions to support research and development in agriculture.
Driver: Advances in genetic modification and gene editing technologies
Advances in genetic modification (GM) and gene editing technologies have catalyzed a surge in demand for the agrigenomics market, revolutionizing the landscape of modern agriculture. GM techniques, such as CRISPR-Cas9, enable precise manipulation of genes in crops and livestock, allowing for targeted modifications that enhance desirable traits. This has significantly accelerated the development of genetically modified organisms (GMOs) with improved yields, resistance to pests and diseases, and enhanced nutritional profiles. Gene editing technologies offer unprecedented precision, enabling researchers to modify specific DNA sequences without introducing foreign genes. The ability to edit the genome at the molecular level has opened up new avenues for crop improvement, allowing for the creation of novel varieties with desired traits, including drought resistance, increased nutritional content, and optimized growth characteristics.
The demand for agrigenomics services has surged as researchers, breeders, and agricultural companies seek advanced tools for genetic analysis, marker-assisted selection, and bioinformatics to harness the full potential of these technologies. As the global population grows and environmental challenges intensify, the agrigenomics market plays a pivotal role in developing sustainable, high-yielding, and resilient agricultural solutions that address the evolving needs of the industry and contribute to global food security. The convergence of genetic modification and gene editing with agrigenomic advancements marks a transformative era for agriculture, driving innovation and shaping the future of food production.
Restraint: High initial costs
The implementation of advanced genetic technologies, including DNA sequencing, genotyping, and gene editing, requires substantial financial investment in equipment, laboratory infrastructure, and skilled personnel. Small and medium-sized farms, as well as agricultural enterprises with limited resources, may find these upfront expenses prohibitive, impeding their ability to embrace agrigenomic solutions. The high initial costs not only encompass the acquisition of cutting-edge technologies but also the ongoing expenses related to maintenance, training, and staying abreast of rapidly evolving methodologies. This financial barrier could create disparities in the adoption of agrigenomics, potentially limiting access for certain stakeholders within the agricultural community.
Moreover, the economic viability of agrigenomic applications may be a concern for farmers who face uncertainties regarding the return on investment and the time it takes to realize benefits. Overcoming this challenge requires strategic efforts from industry players, policymakers, and financial institutions to develop cost-effective solutions, offer financial incentives, and facilitate technology transfer.
Opportunity: Precision breeding and crop improvement
Precision breeding and crop improvement represent a significant growth avenue for the agrigenomics market, positioning it as a cornerstone in the evolution of modern agriculture. With the advent of advanced genomic technologies, such as DNA sequencing and marker-assisted selection, agrigenomics enables researchers and breeders to identify and understand specific genetic traits within crops. This precision breeding approach allows for the development of crops with enhanced characteristics, including improved yield, disease resistance, and adaptability to varying environmental conditions.
Agrigenomics facilitates the selection of desirable traits at the molecular level, accelerating the breeding process by providing insights into the genetic makeup of plants. This targeted approach not only streamlines the development of high-performing crop varieties but also contributes to the creation of sustainable and resilient agricultural systems. The ability to precisely manipulate the genetic composition of crops empowers farmers to address challenges such as climate change, pests, and resource limitations. As the demand for more efficient and sustainable agricultural practices intensifies globally, the agrigenomics market plays a pivotal role in optimizing crop improvement strategies.
The Illumina HiSeq family segment is recorded more than 36% of revenue share in 2023; the segment is observed to continue the trend throughout the forecast period. Illumina HiSeq family is a widely adopted next-generation sequencing (NGS) technology. It utilizes a sequencing-by-synthesis approach, enabling the simultaneous sequencing of millions of DNA fragments. The HiSeq platform is known for its high throughput, speed, and cost-effectiveness, making it a prominent choice in agrigenomics research.
The PacBio Sequencing segment is expected to grow at a significant rate throughout the forecast period. Pacific Biosciences (PacBio) sequencing, also known as single-molecule real-time (SMRT) sequencing, offers long-read capabilities. This technology excels in providing comprehensive genome information, facilitating the study of complex genetic structures and variations in crops and livestock.
The crops segment held the largest market share of 65% in 2023. Agrigenomics plays a pivotal role in crop research and improvement. By analyzing the genetic makeup of various crops, researchers can identify key traits related to yield, disease resistance, nutritional content, and environmental adaptability. Precision breeding techniques, enabled by agrigenomic technologies, contribute to the development of genetically enhanced crop varieties. This includes the creation of plants that are more resilient to changing climatic conditions, exhibit improved resistance to pests and diseases, and have enhanced nutritional profiles. The application of agrigenomics in crops aligns with the global imperative to ensure food security, sustainability, and increased agricultural productivity.
The livestock segment is expected to generate a notable rate of growth in the market. Agrigenomics is equally essential in the context of livestock farming. Genetic analysis of livestock enables the identification of desirable traits related to meat quality, milk production, disease resistance, and overall animal health. By leveraging agrigenomic tools, breeders can selectively enhance genetic traits in livestock, resulting in improved productivity and the development of breeds that are better suited to specific environmental conditions. The application of agrigenomics in livestock is crucial for ensuring sustainable and efficient animal farming practices, addressing challenges such as disease outbreaks and resource constraints.
Segments Covered in the Report
By Sequencer
By Application
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Agrigenomics Market
5.1. COVID-19 Landscape: Agrigenomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Agrigenomics Market, By Sequencer
8.1. Agrigenomics Market, by Sequencer, 2024-2033
8.1.1. Sanger Sequencing
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Illumina Hi Seq Family
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. PacBio Sequencing
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Solid Sequencers
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Other Sequencers
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Agrigenomics Market, By Application
9.1. Agrigenomics Market, by Application, 2024-2033
9.1.1. Crop
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Livestock
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Agrigenomics Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.1.2. Market Revenue and Forecast, by Application (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.1.3.2. Market Revenue and Forecast, by Application (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.2.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.2.3.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.3.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.3.3.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.4.3.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.5.3.2. Market Revenue and Forecast, by Application (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Sequencer (2021-2033)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2033)
Chapter 11. Company Profiles
11.1. Thermo Fisher Scientific, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Agilent Technologies, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Tecan Genomics Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. BGI
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Illumina, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Eurofins Scientific SE
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. LGC Limited
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Arbor Biosciences
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Biogenetic Services Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Galseq Srl Via Italia
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client